Latest Healthcare Research Reports

Tag: Asthma Therapeutics Market – Global Asthma Therapeutics Industry Size

  • Asthma Therapeutics Market to Grow at a CAGR of 7.7% from 2025 to 2029

    Asthma Therapeutics Market to Grow at a CAGR of 7.7% from 2025 to 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Future Market Size Estimation For The Asthma Therapeutics Market Covering 2025–2034?

    The asthma therapeutics market size has experienced significant expansion in recent years. Its valuation is anticipated to climb from $30.63 billion in 2024 to $33.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. This historical growth can be linked to heightened awareness concerning asthma management, the increasing utilization of inhalers and nebulizers, the rising incidence of allergic asthma due to pollution, burgeoning government initiatives for respiratory health, and the developing healthcare infrastructure in emerging economies.

    The asthma therapeutics market is projected to experience substantial growth in the upcoming years. This market is anticipated to reach a valuation of $44.53 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is primarily driven by factors such as the increasing demand for biologics in asthma treatment, a heightened focus on personalized medicine, the expanding adoption of digital inhalers and smart health devices, a rising prevalence of pediatric asthma, and increased investment in research and development for novel therapeutics. Significant trends anticipated within this period include advancements in biologic therapies for severe asthma, sophisticated inhaler technologies with digital tracking functionalities, the development of individualized asthma treatment plans, innovations in drug-delivery mechanisms, and the integration of artificial intelligence and wearable devices for asthma monitoring.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

    Which Major Market Drivers Are Shaping The Future Of The Asthma Therapeutics Market?

    The rising occurrence of asthma is anticipated to drive expansion within the asthma therapeutics market. Asthma is defined as a chronic condition leading to inflammation and swelling of the respiratory passages, which in turn constricts the tubes transporting air from the nose and mouth to the lungs. This growing prevalence of asthma stems from a rise in pollutants that irritate the airways, thereby increasing the likelihood of developing the condition. Asthma treatments aid in managing the condition through controlling inflammation in the airways, alleviating symptoms, and preventing acute asthma episodes. Medications for long-term control, such as inhaled corticosteroids, work to diminish chronic inflammation, whereas rapid-acting drugs like bronchodilators offer immediate symptom relief during acute attacks. As an illustration, figures from April 2024, reported by Asthma + Lung UK, an England-based charity assisting individuals with lung conditions, revealed that asthma-related fatalities in England rose from 1,146 in 2021 to 1,236 in 2022. Consequently, the expanding occurrence of asthma is fueling the market growth for asthma therapeutics.

    What Are The Major Segment Categories Driving The Asthma Therapeutics Market Growth?

    The asthma therapeutics market covered in this report is segmented –

    1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

    2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

    3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Homecare, Specialty Clinics

    Subsegments:

    1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

    2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

    3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

    4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

    5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

    6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

    Which Key Trends Are Expected To Influence The Asthma Therapeutics Market In The Coming Years?

    Leading companies in the asthma therapeutics market are concentrating on developing innovative products, such as fixed-dose combination (FDC) drugs, to boost treatment effectiveness and enhance patient compliance. An FDC drug is a pharmaceutical preparation containing two or more active ingredients combined into a single dosage form, like a tablet or inhaler, intended for treating a specific condition. For example, in June 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, introduced a new fixed-dose combination (FDC) drug, Indacaterol plus Mometasone, for asthma treatment. Indacaterol serves as a long-acting beta-agonist (LABA) that aids in relaxing airway muscles, while Mometasone is an inhaled corticosteroid (ICS) that reduces lung inflammation. This specific FDC aims to provide improved symptom management and convenience via once-daily dosing, thereby enhancing treatment adherence among individuals with moderate to severe asthma.

    Who Are The Major Companies Operating In The Asthma Therapeutics Market?

    Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

    How Does The Asthma Therapeutics Market Perform Across Key Geographic Regions?

    North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Asthma Therapeutics Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

    Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2025, By The Business Research Company

    Asthma Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

    Anti Asthmatics And Copd Drugs Market 2025

    https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

    Anti Asthmatics And Copd Drugs Market 2025

    https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Asthma Therapeutics Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Projected Valuation Of The Asthma Therapeutics Market In The Coming Years?

    In recent times, there has been substantial growth in the asthma therapeutics market. It is projected to expand from $30.63 billion in 2024 to $33.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth, observed in the historical period, can be credited to an increased awareness regarding asthma management, the upsurge in usage of inhalers and nebulizers, a rise in incidence of allergic asthma due to pollution, augmented governmental efforts towards respiratory health, and the expansion of the healthcare infrastructure in emerging economies.

    Expect a surge in the size of the asthma therapeutics market in the following years, as it is predicted to reach $44.53 billion by 2029, developing at a compound annual growth rate of 7.7%. This estimated growth within the forecasted period can be credited to a surge in demand for biologics for asthma therapies, a heightened emphasis on personalized medicine, the growing consumption of digital inhalers and intelligent health gadgets, an increasing incidence of pediatric asthma, and boosted investment into the study and development of groundbreaking therapeutics. Forecasts for the period also spotlight progression in biologic therapies for severe asthma, sophisticated inhaler technologies equipped with digital tracking, the creation of personalized asthma treatment strategies, innovation in drug delivery systems, and the incorporation of artificial intelligence and wearable devices into asthma monitoring.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

    What Drivers Are Accelerating Expansion Of The Asthma Therapeutics Market?

    Expectations for the burgeoning asthma therapeutics market are being fueled by the rising incidence of asthma. Asthma is a long-lasting ailment that triggers swelling and inflammation of the airways, constricting the pathways that transport air from the nose and mouth into the lungs. The surge in asthma cases can be attributed to heightened exposure to pollutants, which end up irritating the airways and heightening the chances of initiating this condition. Asthma therapeutics play a crucial role in managing asthma by counteracting airway inflammation, mitigating symptoms, and thwarting asthma episodes. Persistent control treatments like inhaled corticosteroids diminish prolonged inflammation, whereas rapid-release medications such as bronchodilators offer immediate reprieve during bouts of exacerbation. For example, in April 2024, as per Asthma + Lung UK, a charity based in England that offers support to individuals with lung diseases, there was a report of an increase in the number of deaths due to asthma in England, which rose from 1,146 in 2021 to 1,236 in 2022. Consequently, the escalating incidence of asthma is spearheading the expansion of the asthma therapeutics market.

    How Is The Global Asthma Therapeutics Market Broken Down By Segment?

    The asthma therapeutics market covered in this report is segmented –

    1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

    2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

    3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Homecare, Specialty Clinics

    Subsegments:

    1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

    2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

    3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

    4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

    5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

    6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

    Which Trends Are Likely To Redefine Growth Paths In The Asthma Therapeutics Market?

    Major firms in the asthma therapeutics sector are strategizing to develop novel products, such as fixed-dose combination (FDC) drugs, with the aim to improve treatment outcomes and patient compliance. An FDC drug merges two or more potent pharmaceutical ingredients into a single dosage form, like a tablet or inhaler, tailored to manage a specific medical condition. For example, Glenmark Pharmaceuticals Limited, a pharmaceutical firm based in India, unveiled an innovative fixed-dose combination (FDC) drug, Indacaterol plus Mometasone, for the treatment of asthma in June 2022. Indacaterol operates as a long-acting beta-agonist (LABA), which aids in relaxing airway muscles, and Mometasone functions as an inhaled corticosteroid (ICS), working towards reducing inflammation in the lungs. The design of this FDC aims to provide superior control of symptoms and user-friendly, once-daily dosing, boosting the treatment compliance among moderate to severe asthma patients.

    Which Firms Are Making The Biggest Impact In The Asthma Therapeutics Market?

    Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

    Which Geographic Regions Are Creating Strong Demand In The Asthma Therapeutics Market?

    North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

    Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2025, By The Business Research Company

    Asthma Spacers Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/asthma-spacers-global-market-report

    Respiratory Disease Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

    Allergic Rhinitis Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Asthma Therapeutics Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

    Asthma Therapeutics Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Projected Valuation Of The Asthma Therapeutics Market In The Coming Years?

    In recent times, there has been substantial growth in the asthma therapeutics market. It is projected to expand from $30.63 billion in 2024 to $33.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth, observed in the historical period, can be credited to an increased awareness regarding asthma management, the upsurge in usage of inhalers and nebulizers, a rise in incidence of allergic asthma due to pollution, augmented governmental efforts towards respiratory health, and the expansion of the healthcare infrastructure in emerging economies.

    Expect a surge in the size of the asthma therapeutics market in the following years, as it is predicted to reach $44.53 billion by 2029, developing at a compound annual growth rate of 7.7%. This estimated growth within the forecasted period can be credited to a surge in demand for biologics for asthma therapies, a heightened emphasis on personalized medicine, the growing consumption of digital inhalers and intelligent health gadgets, an increasing incidence of pediatric asthma, and boosted investment into the study and development of groundbreaking therapeutics. Forecasts for the period also spotlight progression in biologic therapies for severe asthma, sophisticated inhaler technologies equipped with digital tracking, the creation of personalized asthma treatment strategies, innovation in drug delivery systems, and the incorporation of artificial intelligence and wearable devices into asthma monitoring.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

    What Drivers Are Accelerating Expansion Of The Asthma Therapeutics Market?

    Expectations for the burgeoning asthma therapeutics market are being fueled by the rising incidence of asthma. Asthma is a long-lasting ailment that triggers swelling and inflammation of the airways, constricting the pathways that transport air from the nose and mouth into the lungs. The surge in asthma cases can be attributed to heightened exposure to pollutants, which end up irritating the airways and heightening the chances of initiating this condition. Asthma therapeutics play a crucial role in managing asthma by counteracting airway inflammation, mitigating symptoms, and thwarting asthma episodes. Persistent control treatments like inhaled corticosteroids diminish prolonged inflammation, whereas rapid-release medications such as bronchodilators offer immediate reprieve during bouts of exacerbation. For example, in April 2024, as per Asthma + Lung UK, a charity based in England that offers support to individuals with lung diseases, there was a report of an increase in the number of deaths due to asthma in England, which rose from 1,146 in 2021 to 1,236 in 2022. Consequently, the escalating incidence of asthma is spearheading the expansion of the asthma therapeutics market.

    How Is The Global Asthma Therapeutics Market Broken Down By Segment?

    The asthma therapeutics market covered in this report is segmented –

    1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

    2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

    3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Homecare, Specialty Clinics

    Subsegments:

    1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

    2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

    3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

    4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

    5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

    6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

    Which Trends Are Likely To Redefine Growth Paths In The Asthma Therapeutics Market?

    Major firms in the asthma therapeutics sector are strategizing to develop novel products, such as fixed-dose combination (FDC) drugs, with the aim to improve treatment outcomes and patient compliance. An FDC drug merges two or more potent pharmaceutical ingredients into a single dosage form, like a tablet or inhaler, tailored to manage a specific medical condition. For example, Glenmark Pharmaceuticals Limited, a pharmaceutical firm based in India, unveiled an innovative fixed-dose combination (FDC) drug, Indacaterol plus Mometasone, for the treatment of asthma in June 2022. Indacaterol operates as a long-acting beta-agonist (LABA), which aids in relaxing airway muscles, and Mometasone functions as an inhaled corticosteroid (ICS), working towards reducing inflammation in the lungs. The design of this FDC aims to provide superior control of symptoms and user-friendly, once-daily dosing, boosting the treatment compliance among moderate to severe asthma patients.

    Which Firms Are Making The Biggest Impact In The Asthma Therapeutics Market?

    Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

    Which Geographic Regions Are Creating Strong Demand In The Asthma Therapeutics Market?

    North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

    Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2025, By The Business Research Company

    Asthma Spacers Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/asthma-spacers-global-market-report

    Respiratory Disease Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

    Allergic Rhinitis Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

    Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Large Is the Asthma Therapeutics Market Expected to Be in 2029?

    The market size of asthma therapeutics has witnessed robust growth lately. The sector, which was valued at $30.63 billion in 2024, is projected to reach $33.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. This growth during the historic phase has been propelled by an enhanced understanding of asthma management, wider usage of inhalers and nebulizers, an increased incidence of allergic asthma due to pollution, government actions prioritizing respiratory health, and a developing healthcare infrastructure in burgeoning economies.

    The market size of asthma therapeutics is predicted to witness substantial expansion in the approaching years. The market is set to rise to $44.53 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. This projected growth over the forecast period can be linked to a surge in demand for biologics in the treatment of asthma, an escalating emphasis on personalized medicine, a growing adoption of smart health devices and digital inhalers, an increase in cases of pediatric asthma, and heightened investment in the research and development of innovative therapeutics. Key trends over the forecast period are expected to be the progress in biologic treatments for severe asthma, the evolution of inhaler technologies with digital tracking capabilities, the development of personalized asthma management plans, advancements in drug delivery systems, and the incorporation of artificial intelligence and wearable tech in the monitoring of asthma.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

    What Are The Contributors To Demand In The Asthma Therapeutics Market?

    The surge in asthma cases is projected to fuel the expansion of the asthma therapeutics market. Asthma is a chronic illness characterized by inflammation and swelling of the air passage, leading to the constricting of airways that transport air from the nose and mouth to the lungs. The rise in asthma cases can be attributed to escalating pollutants that agitate the airways, increasing the likelihood of contracting the condition. Asthma therapeutics aim to manage asthma by alleviating symptoms, controlling airway inflammation, and averting asthma attacks. Inhaled corticosteroids, which are long-term control medicines, minimize chronic inflammation, while immediate relief is provided by quick-relief medications like bronchodilators during flare-ups. Asthma + Lung UK, a charity based in England that advocates for individuals with lung conditions, reported that asthma-related fatalities in England rose from 1,146 in 2021 to 1,236 in 2022 in April 2024. Consequently, the escalating cases of asthma are propelling the expansion of the asthma therapeutics market.

    What Segmentation Categories Are Included In The Asthma Therapeutics Market Analysis?

    The asthma therapeutics market covered in this report is segmented –

    1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

    2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

    3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    5) By End-User: Hospitals, Homecare, Specialty Clinics

    Subsegments:

    1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

    2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

    3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

    4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

    5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

    6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

    What Upcoming Trends Are Expected To Impact The Asthma Therapeutics Market Globally?

    Leading businesses in the asthma therapeutics market are striving to pioneer novel products like fixed-dose combination (FDC) drugs to bolster treatment effectiveness and elevate patient compliance. An FDC drug integrates two or more active medicinal ingredients into a single dose form, such as an inhaler or tablet, designed to address a specific ailment. Take for example, in June 2022, India’s Glenmark Pharmaceuticals Limited introduced a new FDC drug, Indacaterol plus Mometasone, intended for the treatment of asthma. Indacaterol functions as a long-acting beta-agonist (LABA) that relaxes the muscles in the airways, while Mometasone serves as an inhaled corticosteroid (ICS) that mitigates lung inflammation. This FDC is meant to provide enhanced symptoms management and convenience with daily single dosing, thereby improving treatment observance among patients suffering from moderate to severe asthma.

    Who Are The Top-Ranked Companies In The Asthma Therapeutics Market Today?

    Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, ALK-Abello, Mylan N.V., Whanin Pharmaceutical, Mitsubishi Tanabe Pharma, Allergan plc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

    How Is Asthma Therapeutics Market Adoption Varying Across Different Regions And Sectors?

    North America was the largest region in the asthma therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model